.
.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
http://lm360.us/Gioacchini-son-of-Dawood-from-Corsley-Heath?Ziedangra=252 november 17, 2014
.
.
.